nitrendipine has been researched along with Alloxan Diabetes in 9 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigates the efficacy of late intervention with the calcium channel blockers (CCBs) nitrendipine and nisoldipine in preventing development of albuminuria and glomerular hypertrophy in experimental diabetes." | 3.70 | Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats. ( Flyvbjerg, A; Grønbaek, H; Nielsen, B; Osterby, R, 2000) |
| "Nitrendipine treatment was unable to prevent increased GBM in diabetic SHR." | 1.30 | Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion. ( Flyvbjerg, A; Grønbaek, H; Nielsen, B; Osterby, R, 1999) |
| "Enalapril treatment (5 mg/kg/day, n = 11) or felodipine (30 mg/kg/day, n = 11) reduced systolic blood pressure to a comparable degree." | 1.27 | Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. ( Cubela, R; Debrevi, L; Jackson, B; Johnston, CI; Whitty, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armenia, A | 2 |
| Munavvar, AS | 1 |
| Abdullah, NA | 3 |
| Helmi, A | 1 |
| Johns, EJ | 3 |
| Sattar, MA | 2 |
| Khan, MA | 2 |
| Kato, S | 1 |
| Ishida, H | 1 |
| Tsuura, Y | 1 |
| Okamoto, Y | 1 |
| Tsuji, K | 1 |
| Horie, M | 1 |
| Okada, Y | 1 |
| Seino, Y | 1 |
| Nielsen, B | 2 |
| Grønbaek, H | 2 |
| Osterby, R | 2 |
| Flyvbjerg, A | 2 |
| Lee, SL | 2 |
| Dhalla, NS | 2 |
| Ostadalova, I | 1 |
| Kolar, F | 1 |
| Jackson, B | 1 |
| Cubela, R | 1 |
| Debrevi, L | 1 |
| Whitty, M | 1 |
| Johnston, CI | 1 |
9 other studies available for nitrendipine and Alloxan Diabetes
| Article | Year |
|---|---|
The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats.
Topics: Animals; Blood Glucose; Clonidine; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Res | 2004 |
Alpha1A- and alpha1D-adrenoceptors are the major functional subtypes of renal alpha1-adrenoceptors in streptozotocin-induced diabetic and normal Sprague-Dawley rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Diabetes Mellitus, Expe | 2008 |
Functional subtypes of renal alpha1-adrenoceptor in diabetic and non-diabetic 2K1C Goldblatt renovascular hypertension.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Clonidine; D | 2008 |
Increased calcium-channel currents of pancreatic beta cells in neonatally streptozocin-induced diabetic rats.
Topics: Animals; Animals, Newborn; Barium; Calcium Channels; Cells, Cultured; Diabetes Mellitus, Experimenta | 1994 |
Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion.
Topics: Albuminuria; Animals; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Hypertension; Kidne | 1999 |
Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Ex | 2000 |
Ca(2+)-channels and adrenoceptors in diabetic skeletal muscle.
Topics: Animals; Calcium Channels; Diabetes Mellitus, Experimental; Dihydroalprenolol; Kinetics; Male; Muscl | 1992 |
Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy.
Topics: Animals; Blood Glucose; Brain; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cardiomyopat | 1992 |
Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Diabetes Mellitus, Expe | 1987 |